ISRCTN07830951已完成未知
The use of Carer Assisted Adherence Therapy for people with PARKinson?s disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial
niversity of East Angia (UK)0 个研究点目标入组 80 人开始时间: 2011年9月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
- 2011 study protocol in http://www.ncbi.nlm.nih.gov/pubmed/22122912 2. 2014 results in https://www.ncbi.nlm.nih.gov/pubmed/24750544
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 20/12/2011
- •1. Adults diagnosed with, or with probable, Idiopathic PD (three out of four of the chief UK Brain Bank criteria)
- •2. Prescribed one or more anti-parkinsonian medications by a Consultant Neurologist or Consultant Physician with specialist knowledge of movement disorders
- •3. English speaking and literate (participants are required to actively engage in the therapy process)
- •4. Stable medication regime i.e. not altered within the previous month, and not expected to change during the period of the research project (12 weeks)
- •5. Not demented or significantly cognitively impaired as assessed either informally by the clinical team or formally using the Mini-Mental State Examination (MMSE) score of = 24 (recent clinic score used where available)
- •6. Show poor adherence as determined by a Morisky Medication Adherence Scale (MMAS-4) score of 1 or above
- •Previous inclusion criteria
- •1. Adults diagnosed with, or with probable, Idiopathic PD (three out of four of the chief UK Brain Bank criteria)
- •2. Prescribed one or more anti-parkinsonian medications by a Consultant Neurologist or Consultant Physician with specialist knowledge of movement disorders
- •3. English speaking and literate (participants are required to actively engage in the therapy process)
- •4. Stable medication regime i.e. not altered within the previous month, and not expected to change during the period of the research project (12 weeks)
- •5. Not demented or significantly cognitively impaired as assessed either informally by the clinical team or formally using the Mini-Mental State Examination (MMSE) score of = 24 (recent clinic score used where available)
- •6. Show poor adherence as determined by a Morisky Medication Adherence Scale (MMAS-4) score = 2
排除标准
- •1. Suspected Parkinsonism due to other causes than idiopathic PD
- •2. Treated with anti-parkinsonian medications for a mental health complaint
- •3. Diagnosed with dementia
- •4. Life expectancy < 6 months
研究者
相似试验
已完成
不适用
Customized Medication Adherence Enhancement for Adults With Bipolar DisorderBipolar DisorderNCT00830310University Hospitals Cleveland Medical Center43
已完成
不适用
Patient-Centered Adherence Intervention After Acute Coronary Syndrome (ACS) HospitalizationAcute Coronary SyndromeNCT00903032US Department of Veterans Affairs253
已完成
不适用
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech RepublicGrowth DisordersNCT01400997Merck KGaA, Darmstadt, Germany206
招募中
不适用
Treatment adherence therapy in non-adherent patients with psychotic disorders; a randomised trial.1. Schizophrenia<br />2. psychosis<br />(NLD: schizofrenie, psychose).NL-OMON26923Erasmus MC University, Rotterdam, THE NETHERLANDS120
已完成
不适用
Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent ImplantationCoronary Artery Stent ThrombosisMultiple Drug UsePatient ComplianceNCT01689493Hôpital de la Timone800